HKEX: 2269 - WuXi Biologics (Cayman) Inc.

Yield per half year: +108.15%
Dividend yield: 0.00%
Sector: Healthcare

Current price
27.85 HK$
Average price
17.05 HK$ -38.78%

Price based on EPS
11.28 HK$ -59.49%
Price according to DCF model (ebitda)
37.36 HK$ +34.15%
3.33/10
30.0030.0025.0025.0020.0020.0015.0015.0010.0010.005.005.00Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25

Price based on EPS

Price = EPS * (1 + CAGR EPS) / (Key Rate * Excess Key Rate)
Key Rate = Key rate
Fair price = 11.28 HK$
Current price = 27.85 HK$ (difference = -59.49%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 37.36 HK$
Current price = 27.85 HK$ (difference = +34.15%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 2.51 HK$
Current price = 27.85 HK$ (difference = -91%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription